Begül Yağcı-Küpeli

8PUBLICATIONS
14CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 09, 2026
SUVmax on 18F-FDG PET/CT and Histopathological Necrosis in Osteosarcoma and Ewing Sarcoma.

Şule Çalışkan Kamış, Metin Çil, Emel Koçyiğit Deveci

|Jan 10, 2026
Diagnostic Value of CA-125 and Other Tumor Biomarkers in Children with Suspected Malignancy: A Retrospective Cohort Study.

Şule Çalışkan Kamış, Metin Çil, Begül Yağcı

|Dec 09, 2024
Hoyeraal-Hreidarsson syndrome: a case report of dyskeratosis congenita with a novel PARN gene mutation.

Şule Çalişkan Kamiş, Metin Çil, Begül Yağci-Küpeli

|Mar 13, 2024
Nimotuzumab-vinorelbine combination therapy versus other regimens in the treatment of pediatric diffuse intrinsic pontine glioma.

Ayşe Özkan, Begül Yağcı Küpeli, Serhan Küpeli

|Mar 02, 2023
Bevacizumab-containing regimens for children with relapsed or refractory tumors.

Begül Yağcı-Küpeli, Duygu Pehlivan

|Jan 16, 2022
Trans-Arterial Radioembolization with Yttrium-90 of Unresectable and Systemic Chemotherapy Resistant Hepatoblastoma in Three Toddlers.

Huseyin Tugsan Balli, Kairgeldy Aikimbaev, Isa Burak Guney

Pageof 2

Frequent Collaborators

3 joint publications

Şule Çalışkan Kamış

3 joint publications

Metin Çil

2 joint publications

Tuğsan Ballı

2 joint publications

Serhan Kupeli